SCHEMBL2425236

SCHEMBL2425236

Cc1cc2nc(Cl)c(NS(=O)(=O)c3ccccc3Cl)nc2cc1C

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RXFP1 Q9HBX9 8/20 0.71
▸ ALDH1A1 P00352 6/20 0.71
▸ L3MBTL1 Q9Y468 2/20 0.71
▸ MEN1 O00255 3/20 0.59
▸ KMT2A Q03164 3/20 0.59
▸ CRHBP P24387 1/20 0.59
▸ CRHR2 Q13324 1/20 0.59
▸ KDM4E B2RXH2 5/20 0.52
▸ NPSR1 Q6W5P4 1/20 0.52
▸ SMN1; SMN2 Q16637 2/20 0.50
▸ POLB P06746 2/20 0.50
▸ HPGD P15428 2/20 0.50
▸ GAA P10253 2/20 0.49
▸ LMNA P02545 2/20 0.49
▸ MAPT P10636 1/20 0.49
▸ PKM P14618 1/20 0.49
▸ HTT P42858 2/20 0.48
▸ CCR4 P51679 1/20 0.47
▸ EDNRA P25101 1/20 0.47
▸ BRD4 O60885 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2304255 0.87 RXFP1 (0.76) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4682254 0.80 RXFP1 (0.57) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL2419211 0.78 RXFP1 (0.70) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL2301852 0.76 RXFP1 (1.00) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4684562 0.76 CCR4 (0.58) RXFP1ALDH1A1L3MBTL1CCR4
SCHEMBL2304579 0.75 RXFP1 (0.79) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL12283464 0.74 CCR4 (0.42) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL4684020 0.73 CCR4 (0.55) RXFP1ALDH1A1L3MBTL1CCR4
SCHEMBL2421801 0.73 RXFP1 (0.72) RXFP1ALDH1A1L3MBTL1MEN1KMT2A
SCHEMBL10044457 0.73 RXFP1 (0.71) RXFP1ALDH1A1L3MBTL1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2374802-B1 KYNURENINE PRODUCTION INHIBITOR KYOWA HAKKO KIRIN CO LTD (JP) 2014-04-23 — — EP disclosed
US-8673908-B2 Kynurenine production inhibitor KYOWA HAKKO KIRIN CO., LTD. (JP) 2014-03-18 — — US disclosed
EP-2374802-A1 KYNURENINE PRODUCTION INHIBITOR Kyowa Hakko Kirin Co., Ltd. (JP) 2011-10-12 — — EP disclosed
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYOWA KIRIN CO., LTD. (JP) 2011-09-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110237584-A1 KYNURENINE PRODUCTION INHIBITOR KYNU, KMO, IDO1 RXFP1 81/4885ALDH1A1 1689/4885L3MBTL1 631/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback